Various radiopharmaceuticals

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0025DA004
Awardee
Awarding agency
Task orders
2 $242,721 obligated

Award facts

Opportunity
Combined order value
$242,721 Current and potential, with all options
Last date to order 100% complete
Maximum order
$242,620.70
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded a single-award indefinite-delivery contract to Cardinal Health 414, LLC with a ceiling of $242,720.70 on October 1, 2025, for various radiopharmaceuticals and transfer of administrative responsibilities. Place of performance is JBSA Fort Sam Houston, Texas. The originating solicitation, issued by the Medical Readiness Contracting Office - West as a pre-solicitation sources sought notice posted June 24, 2025, sought radiopharmaceutical supply on an as-needed basis to the Nuclear Medicine Clinic at Brooke Army Medical Center, including Ultratag kit, Ioflupane, I-123 caps, MAG3 Kit, MAA, Sestamibi, PYP, and Ultra Technekow 11Ci, with delivery requirements as stringent as two days for certain products. The contract runs from October 1, 2025, through September 30, 2026, with no options stated. The anticipated structure included a twelve-month base period followed by four additional twelve-month option periods, though the final contract reflects a single-year term. A delivery order for $242,620.70 in various radiopharmaceuticals was issued January 20, 2026, with performance at JBSA Fort Sam Houston, firm fixed price, and completion September 30, 2026. A second delivery order for one hundred dollars was issued September 26, 2025, for various radiopharmaceuticals and post-award conference activities, also to JBSA Fort Sam Houston. Cardinal Health 414 manufactures and distributes diagnostic radiopharmaceuticals including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose, and gallium-67, and holds exclusive federal manufacturing and distribution rights for Lymphoseek and serves as the sole authorized federal supplier of Xofigo for prostate cancer treatment.

Task orders

Task order Ordering agency Obligated Awarded
Various radiopharmaceuticals W81K0026FA044 Medical Command (Army) $242,621
Various radiopharmaceuticals // post-award conference W81K0025FA230 Medical Command (Army) $100

Transactions

Action Obligated Date
Other Administrative Action P00001 · Transfer admin responsibilities-various radiopharmaceuticals $0
Original award $0

Quick answers

Who was awarded contract W81K0025DA004?

W81K0025DA004 was awarded to Cardinal Health 414, LLC by Medical Command (Department of the Army) on October 1, 2025.

How much is contract W81K0025DA004 worth?

Orders under W81K0025DA004 have obligated $242,721. A single order can be worth up to $242,621.

How many orders have been placed under contract W81K0025DA004?

2 orders have been placed under W81K0025DA004, the latest on January 20, 2026.

Which agency awarded contract W81K0025DA004?

Medical Command (Department of the Army) awarded W81K0025DA004, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0025DA004?

W81K0025DA004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0025DA004 competed?

The extent of competition for W81K0025DA004 was competed under sap. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV